| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| UNITED STATES | 59.0 | | | | | 34.6 | 29.6 | |
| Government Contracts Concentration Risk | 71.4 | | | | | 34.4 | 29.4 | 24.3 |
| Total revenues | 74.1 | | | | | 40.7 | 34.1 | 29.0 |
| Revenue growth | | | | | | 113.9% | 190.7% | 445.5% |
| Cost of goods sold | 30.1 | | | | | 40.2 | 34.7 | 28.7 |
| Gross profit | 44.0 | | | | | 0.5 | -0.7 | 0.3 |
| Gross margin | 59.4% | | | | | 1.2% | -1.9% | 1.1% |
| Selling, general and administrative [+] | 77.1 | | | | | 100.7 | 86.7 | 65.6 |
| Sales and marketing | 56.4 | | | | | 72.0 | | 58.0 |
| General and administrative | | | | | | | 28.7 | |
| Research and development | 0.9 | | | | | 0.2 | 0.1 | 0.2 |
| Equity in earnings | 1.2 | | | | | 1.1 | 1.0 | 0.7 |
| EBITDA [+] | -32.8 | | | | | -105.7 | -92.7 | -71.0 |
| EBITDA growth | | | | | | 373.5% | 477.6% | 553.7% |
| EBITDA margin | -44.3% | | | | | -259.7% | -272.0% | -244.8% |
| Depreciation and amortization | 40.5 | | | | | 12.6 | 8.0 | 6.5 |
| EBIT [+] | -73.3 | | | | | -118.3 | -100.7 | -77.9 |
| EBIT growth | | | | | | 280.1% | 355.8% | 474.5% |
| EBIT margin | -99.0% | | | | | -290.8% | -295.5% | -268.4% |
| Interest expense, net [+] | 5.0 | | | | | 5.3 | 5.2 | 4.8 |
| Interest expense | 7.0 | | | | | 5.3 | 5.2 | 4.8 |
| Interest income | 2.0 | | | | | | | |
| Other income (expense), net [+] | -0.9 | | | | | 46.5 | -119.7 | -159.1 |
| Unrealized gain/loss on derivatives | -1.2 | | | | | 46.0 | 23.9 | -11.3 |
| Change in fair value of warrants | -1.2 | | | | | 46.0 | 23.9 | -11.3 |
| Other | 0.3 | | | | | -3.6 | -147.7 | -147.8 |
| Pre-tax income | -79.2 | | | | | -95.4 | -244.0 | -260.1 |
| Income taxes | 0.1 | | | | | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | | 0.0% | 0.0% | 0.0% |
| Net income | -78.7 | | | | | -97.1 | -245.6 | -261.4 |
| Net margin | -106.2% | | | | | -238.6% | -720.7% | -901.4% |
| |
| Basic EPS [+] | ($0.64) | | | | | ($1.21) | ($2.21) | ($2.59) |
| Growth | | | | | | -51.8% | 85.9% | 156.8% |
| Diluted EPS [+] | ($0.64) | | | | | ($1.21) | ($2.21) | ($2.59) |
| Growth | | | | | | -51.8% | 85.9% | 156.8% |
| |
| Shares outstanding (basic) [+] | 124.4 | | | | | 78.7 | 110.4 | 100.5 |
| Growth | | | | | | -1.9% | 391.2% | 523.6% |
| Shares outstanding (diluted) [+] | 124.4 | | | | | 78.7 | 110.4 | 100.5 |
| Growth | | | | | | -1.9% | 391.2% | 523.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |